Home LiteratureArticle Details
PMID: 21566225 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.

Molecular & cellular proteomics : MCP ·Vol. 10 ·No. 8 ·2011-08-00 ·Pages M111.010462

Kaller M, Liffers ST, Oeljeklaus S, Kuhlmann K, Röh S, Hoffmann R, Warscheid B, Hermeking H

Abstract

The gene encoding the miR-34a microRNA is a transcriptional target of the p53 tumor suppressor protein and subject to epigenetic inactivation in colorectal cancer and numerous other tumor types. Here, we combined pulsed SILAC (pSILAC) and microarray analyses to identify miR-34a-induced changes in protein and mRNA expression. pSILAC allowed to quantify the de novo protein synthesis of 1206 proteins after activation of a conditional miR-34a allele in a colorectal cancer cell line. ∼19% of the detected proteins were differentially regulated, with 113 proteins being down- and 115 up-regulated. The proteins with a miR-34a seed-matching-sequence in the 3'-untranslated region (UTR) of the corresponding mRNA showed a clear bias toward translational repression. Proteins involved in DNA replication, e.g. the MCM proteins, and cell proliferation, were over-represented among indirectly down-regulated proteins lacking a miR-34a seed-match. The decrease in de novo protein synthesis of direct miR-34a targets correlated with reduced levels of the corresponding mRNA in most cases, indicating an interdependence of both types of regulation. In addition, 43 mRNAs encoding proteins not detected by pSILAC were down-regulated after miR-34a expression and contained miR-34a seed-matches. The direct regulation of selected miR-34a target-mRNAs was confirmed using reporter assays. Via down-regulation of the proteins encoded by these mRNAs miR-34a presumably inhibits glycolysis (LDHA), WNT-signaling (LEF1), invasion/migration (AXL) and lipid metabolism (ACSL1, ACSL4). Furthermore, miR-34a may activate p53 by inhibiting its acetylation (MTA2, HDAC1) and degradation (YY1). In summary, miR-34a presumably participates in multiple tumor suppressive pathways by directly and indirectly suppressing the expression of numerous, critical proteins.

MeSH Terms
Cell Line, Tumor Gene Expression Gene Expression Profiling Gene Expression Regulation Genes, Reporter Genes, Tumor Suppressor Genome, Human Humans Isotope Labeling Luciferases, Renilla/biosynthesis,genetics Metabolic Networks and Pathways/genetics MicroRNAs/metabolism,physiology Oligonucleotide Array Sequence Analysis Proteome/genetics,metabolism RNA, Messenger/genetics,metabolism
Chemicals
MIRN34 microRNA, human MicroRNAs Proteome RNA, Messenger Luciferases, Renilla
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kaller Markus
Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich, Thalkirchner Strasse 36, D-80337 Munich, Germany.
Liffers Sven-Thorsten
Oeljeklaus Silke
Kuhlmann Katja
Röh Simone
Hoffmann Reinhard
Warscheid Bettina
Hermeking Heiko
References (68)
68 references, click to expand
  1. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  2. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.
    Nat Biotechnol. 2008 Dec;26(12):1367-72 PMID: 19029910
  3. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Oncogene. 2007 Jul 26;26(34):5017-22 PMID: 17297439
  4. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.
    Mol Ther. 2011 Jun;19(6):1116-22 PMID: 21427705
  5. Role of miR-34c microRNA in the late steps of spermatogenesis.
    RNA. 2010 Apr;16(4):720-31 PMID: 20150330
  6. Frequent downregulation of miR-34 family in human ovarian cancers.
    Clin Cancer Res. 2010 Feb 15;16(4):1119-28 PMID: 20145172
  7. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  8. AXL is a potential target for therapeutic intervention in breast cancer progression.
    Cancer Res. 2008 Mar 15;68(6):1905-15 PMID: 18339872
  9. Combinatorial microRNA target predictions.
    Nat Genet. 2005 May;37(5):495-500 PMID: 15806104
  10. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.
    Nucleic Acids Res. 2005 Sep 07;33(16):e137 PMID: 16147984
  11. p53 regulates mitochondrial respiration.
    Science. 2006 Jun 16;312(5780):1650-3 PMID: 16728594
  12. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Nat Med. 2011 Feb;17(2):211-5 PMID: 21240262
  13. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
    Mol Cell Biol. 2003 Apr;23(8):2669-79 PMID: 12665570
  14. The miR-34 family in cancer and apoptosis.
    Cell Death Differ. 2010 Feb;17(2):193-9 PMID: 19461653
  15. The guardian's little helper: microRNAs in the p53 tumor suppressor network.
    Cancer Res. 2007 Dec 1;67(23):11099-101 PMID: 18056431
  16. A parsimonious model for gene regulation by miRNAs.
    Science. 2011 Feb 4;331(6017):550-3 PMID: 21292970
  17. Most mammalian mRNAs are conserved targets of microRNAs.
    Genome Res. 2009 Jan;19(1):92-105 PMID: 18955434
  18. Human MicroRNA targets.
    PLoS Biol. 2004 Nov;2(11):e363 PMID: 15502875
  19. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression.
    Genes Dev. 2010 Mar 1;24(5):455-69 PMID: 20194438
  20. Inducible microRNA expression by an all-in-one episomal vector system.
    Nucleic Acids Res. 2006;34(18):e119 PMID: 16998186
  21. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
    Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5799-804 PMID: 16585512
  22. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Cancer Res. 2008 Jun 1;68(11):4123-32 PMID: 18519671
  23. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
    Virchows Arch. 2011 Mar;458(3):313-22 PMID: 21225432
  24. MicroRNA targeting specificity in mammals: determinants beyond seed pairing.
    Mol Cell. 2007 Jul 6;27(1):91-105 PMID: 17612493
  25. Probability-based protein identification by searching sequence databases using mass spectrometry data.
    Electrophoresis. 1999 Dec;20(18):3551-67 PMID: 10612281
  26. p53 enters the microRNA world.
    Cancer Cell. 2007 Nov;12(5):414-8 PMID: 17996645
  27. Role for histone deacetylase 1 in human tumor cell proliferation.
    Mol Cell Biol. 2007 Jul;27(13):4784-95 PMID: 17470557
  28. Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling.
    Mol Cell Proteomics. 2007 Dec;6(12):2045-57 PMID: 17768142
  29. Multiple roles for the receptor tyrosine kinase axl in tumor formation.
    Cancer Res. 2005 Oct 15;65(20):9294-303 PMID: 16230391
  30. The interplay between MYC and HIF in cancer.
    Nat Rev Cancer. 2008 Jan;8(1):51-6 PMID: 18046334
  31. RAS is regulated by the let-7 microRNA family.
    Cell. 2005 Mar 11;120(5):635-47 PMID: 15766527
  32. miR-34a repression of SIRT1 regulates apoptosis.
    Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6 PMID: 18755897
  33. Global analysis of cellular protein translation by pulsed SILAC.
    Proteomics. 2009 Jan;9(1):205-9 PMID: 19053139
  34. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Cell Cycle. 2007 Jul 1;6(13):1586-93 PMID: 17554199
  35. Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.
    J Proteome Res. 2011 Feb 4;10(2):479-87 PMID: 21182263
  36. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.
    Mol Cell Proteomics. 2009 Dec;8(12):2796-808 PMID: 19651622
  37. Survivin as a global target of intrinsic tumor suppression networks.
    Cell Cycle. 2009 Sep 1;8(17):2708-10 PMID: 19717980
  38. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.
    Mol Cell Biol. 1991 Oct;11(10):5016-31 PMID: 1656220
  39. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Mol Cell. 2007 Jun 8;26(5):731-43 PMID: 17540598
  40. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
    Science. 2010 Dec 3;330(6009):1340-4 PMID: 21127244
  41. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
    Curr Biol. 2007 Aug 7;17(15):1298-307 PMID: 17656095
  42. The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
    Mol Cell Biol. 2010 Mar;30(5):1171-81 PMID: 20028735
  43. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Nat Cell Biol. 2010 Mar;12(3):247-56 PMID: 20173740
  44. Regulation of mRNA translation and stability by microRNAs.
    Annu Rev Biochem. 2010;79:351-79 PMID: 20533884
  45. Widespread changes in protein synthesis induced by microRNAs.
    Nature. 2008 Sep 4;455(7209):58-63 PMID: 18668040
  46. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation.
    Blood. 2009 Jul 9;114(2):404-14 PMID: 19398721
  47. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.
    FEBS J. 2011 May;278(9):1522-32 PMID: 21366874
  48. Eph-ephrin signalling in adult tissues and cancer.
    Curr Opin Cell Biol. 2008 Apr;20(2):194-200 PMID: 18353626
  49. Structural determinants outside the PXDLS sequence affect the interaction of adenovirus E1A, C-terminal interacting protein and Drosophila repressors with C-terminal binding protein.
    Biochim Biophys Acta. 2001 Mar 9;1546(1):55-70 PMID: 11257508
  50. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.
    Nature. 2010 Apr 15;464(7291):1067-70 PMID: 20305636
  51. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70 PMID: 15295102
  52. MicroRNAs: target recognition and regulatory functions.
    Cell. 2009 Jan 23;136(2):215-33 PMID: 19167326
  53. Gene silencing by microRNAs: contributions of translational repression and mRNA decay.
    Nat Rev Genet. 2011 Feb;12(2):99-110 PMID: 21245828
  54. A novel putative tyrosine kinase receptor with oncogenic potential.
    Oncogene. 1991 Nov;6(11):2113-20 PMID: 1834974
  55. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
    Nature. 2000 Nov 16;408(6810):377-81 PMID: 11099047
  56. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.
    Mol Cell Proteomics. 2002 May;1(5):376-86 PMID: 12118079
  57. Desperately seeking microRNA targets.
    Nat Struct Mol Biol. 2010 Oct;17(10):1169-74 PMID: 20924405
  58. A gene regulation system with four distinct expression levels.
    J Gene Med. 2006 Aug;8(8):1037-47 PMID: 16779863
  59. A microRNA DNA methylation signature for human cancer metastasis.
    Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61 PMID: 18768788
  60. Surfing the p53 network.
    Nature. 2000 Nov 16;408(6810):307-10 PMID: 11099028
  61. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
    Cell. 2006 Jul 14;126(1):107-20 PMID: 16839880
  62. The genomic landscapes of human breast and colorectal cancers.
    Science. 2007 Nov 16;318(5853):1108-13 PMID: 17932254
  63. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.
    Oncogene. 2011 Jun 23;30(25):2888-99 PMID: 21317930
  64. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.
    Cell Cycle. 2008 Aug 15;7(16):2591-600 PMID: 18719384
  65. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
    Cancer Res. 2010 Jul 15;70(14):5923-30 PMID: 20570894
  66. Yin Yang 1 is a negative regulator of p53.
    Cell. 2004 Jun 25;117(7):859-72 PMID: 15210108
  67. On the origin of cancer cells.
    Science. 1956 Feb 24;123(3191):309-14 PMID: 13298683
  68. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.
    Cancer Cell. 2006 Jun;9(6):425-34 PMID: 16766262
Article Info
Journal
Molecular & cellular proteomics : MCP
Abbr.
Mol Cell Proteomics
ISSN
1535-9484
Published
2011-08-00
Epub
2011-00-12
Pages
M111.010462
Language
English
Region
United States
NLM ID
101125647
PMCID
PMC3149097
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com